Pfizer考虑出售医院药品单位以减债并取悦活跃投资者。 Pfizer considers selling its hospital drugs unit to cut debt and please activist investors.

Pfizer正在探索其医院药品单位的销售,其中包括抗生素和无菌注射器,作为撤资非核心资产和减少其615亿美元债务的努力的一部分。 Pfizer is exploring the sale of its hospital drugs unit, which includes antibiotics and sterile injectables, as part of efforts to divest non-core assets and reduce its $61.5 billion debt. 此举是在激进投资者 Starboard Value 的压力下做出的，正值辉瑞首席执行官计划在股价下跌的情况下重新定位公司。 This move follows pressure from activist investor Starboard Value and comes as Pfizer's CEO aims to reposition the company amid declining shares. 该单位可能价值数十亿美元,可吸引制药公司和私人股权团体的兴趣。 The unit, worth potentially billions, could attract interest from pharmaceutical firms and private equity groups.